{"Acute hepatitis B": 79.25371624289451, "Acute myeloid leukaemia": 4.141104142459735, "Acute respiratory distress syndrome": 3.929758691381151, "Agranulocytosis": 21.35592202430412, "Anaemia": 2.2912328545258185, "B-cell lymphoma recurrent": 87.60224945377034, "Bicytopenia": 13.29593638447238, "Bone marrow failure": 12.71043646351251, "Cardiac failure": 2.4229411027673846, "Cardiomyopathy": 4.673806257893796, "Cytomegalovirus infection": 3.8908767942613873, "Cytopenia": 12.43871708505698, "Dermatitis exfoliative generalised": 5.151369433240756, "Diffuse large B-cell lymphoma recurrent": 49.93232641021019, "Disease progression": 4.188394116159946, "Disease recurrence": 2.5983683547370484, "Ejection fraction decreased": 3.183457138654644, "Febrile bone marrow aplasia": 57.595154942346966, "Febrile neutropenia": 20.043343567149268, "Full blood count decreased": 6.508644197216642, "Granulocyte count decreased": 37.55484819352679, "Granulocytopenia": 12.529442163376215, "Haemoglobin decreased": 2.2126612255206, "Hepatic cytolysis": 3.685245391831023, "Hepatic failure": 2.262710952945633, "Hepatitis B": 12.968281761654218, "Hepatitis B reactivation": 60.83092471733034, "Hyperpyrexia": 2.147906795748211, "Hypogammaglobulinaemia": 15.9027082667804, "Infection": 3.3525329448264727, "Infusion related reaction": 3.663189675439032, "Intentional product use issue": 4.341645693306297, "Interstitial lung disease": 6.6573274215883895, "Leukopenia": 10.523752922640986, "Lung disorder": 3.182178222229484, "Lung infiltration": 4.979017783483184, "Lymphoma": 4.692779402081943, "Lymphopenia": 8.472184485878547, "Mucosal inflammation": 4.347918998995172, "Multiple organ dysfunction syndrome": 2.6259913780759443, "Myelodysplastic syndrome": 5.493830037244657, "Myelosuppression": 48.20506914867611, "Neurotoxicity": 2.570163794905357, "Neutropenia": 10.243648404601656, "Neutrophil count decreased": 24.457928119942896, "Off label use": 2.260354664197113, "Pancytopenia": 8.996925630102426, "Platelet count decreased": 5.394000368332808, "Pneumocystis jirovecii pneumonia": 44.47282078568343, "Pneumonia": 3.0360029408749725, "Pneumonitis": 5.992381102178824, "Polyneuropathy": 7.078936670215466, "Progressive multifocal leukoencephalopathy": 89.70245689681086, "Pulmonary fibrosis": 5.333651518425477, "Respiratory tract infection": 2.403266910951043, "Sepsis": 3.1313110083870197, "Septic shock": 6.096958661345178, "Splenomegaly": 4.46286423994748, "Therapy partial responder": 4.146999215443456, "Thrombocytopenia": 4.222436013787468, "Tumour lysis syndrome": 5.392357082724299, "White blood cell count decreased": 18.83444965643559}